📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM). (2023)

First Author: Perico N

Attributed to: Integrative genomic, epigenetic and functional studies in diabetic kidney disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1681/asn.0000000000000189

PubMed Identifier: 37560967

Publication URI: http://europepmc.org/abstract/MED/37560967

Type: Journal Article/Review

Volume: 34

Parent Publication: Journal of the American Society of Nephrology : JASN

Issue: 10

ISSN: 1046-6673